Evidence map›Paper›PMID 42275698›Full record

ArticleRedox biology2026

Biotin-switch technique/proximity ligation assay-based method for in situ analysis of S-nitrosylated proteins.

Mélina Meunier, Emma Levieux, Stéphanie Plenchette

Abstract read
In one paragraph

Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mélina MeunierUniversité Bourgogne Europe, EPHE, INSERM, CTM UMR 1231, 21000 Dijon, France; EPHE, PSL University, Paris, France.
Emma LevieuxUniversité Bourgogne Europe, EPHE, INSERM, CTM UMR 1231, 21000 Dijon, France; EPHE, PSL University, Paris, France.
Stéphanie PlenchetteUniversité Bourgogne Europe, EPHE, INSERM, CTM UMR 1231, 21000 Dijon, France; EPHE, PSL University, Paris, France. Electronic address: stephanie.plenchette-colas@ephe.psl.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) influences a multitude of physiological and pathological processes. A major part of NO signaling involves S-nitrosylation (SNO), a post-translational modification in which an NO moiety is added to a selective cysteine thiol of a protein to form an S-nitrosothiol. Per se, S-nitrosylation is implicated in the control of tissue homeostasis and dysregulated basal levels of S-nitrosylation can contribute to malignant diseases. Importantly, exploiting NO bioactivity through S-nitrosylation represents a therapeutic interest in many diseases. S-nitrosylated protein analysis has been the subject of various methods of detection, quantification and identification, and the Biotin-Switch Technique (BST) is the reference method. Here, a new methodology combining BST and Proximity Ligation Assay (PLA) is presented for the in situ analysis of selective protein S-nitrosylation. This newly developed method termed "SNO-Biotin-PLA" provides the advantage of filling a gap in current methods for studying protein S-nitrosylation in situ.

Indexed as

BiotinNitric OxideProtein Processing, Post-TranslationalProteinsS-NitrosothiolsAnimalsBiotinylationCysteineHumansBiotinCysteineNitric OxideProteinsS-NitrosothiolsBiotin-switch techniqueNitric oxideProximity ligation assaySignalingS-nitrosylation

Identifiers

PMID42275698
PMCPMC13272535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.